Rapid automated enzyme immunoassay of serum amyloid A.
Serum amyloid A (SAA), a sensitive acute-phase protein, is the precursor of AA fibrils in reactive amyloidosis. However, SAA is poorly immunogenic, and development and standardization of immunoassays of this protein have been difficult. We established an automated polyclonal/monoclonal microparticle capture enzyme immunoassay, standardized with the World Health Organization prospective reference standard for SAA. A stabilized concentrate of SAA was used for controls and calibrators. The assay range was 1-750 mg/L with CVs < 7% throughout. Plasma and serum gave identical results and no interferences were observed. Linear regression against radial immunodiffusion assay gave a slope of 1.04 (95% confidence interval 0.99-1.10), intercept of -9 mg/L (95% confidence interval -14-3), and residual SD (SEE) of 20 for samples containing < or = 200 mg/L (n = 173). In 105 apparently healthy adults the mean (SD) SAA concentration was 3.7 (3.6) mg/L, the median was 3.0 mg/L, and the range, 0.7-26.4 mg/L. In clinical acute-phase sera, values up to 2200 mg/L were seen. This method will facilitate measurement and investigation of SAA in clinical practice generally and in AA amyloidosis.
Abbott Diagnostics Division, Abbott Laboratories, North Chicago, IL 60064.
J
J
Wilkins
J R
JR
Gallimore
G A
GA
Tennent
P N
PN
Hawkins
P C
PC
Limburg
M H
MH
van Rijswijk
E G
EG
Moore
M B
MB
Pepys
D000210:Acute-Phase Reaction / Q000097:blood; D000328:Adult; D000686:Amyloidosis / Q000097:blood; D001322:Autoanalysis / Q000379:methods*; D004355:Drug Stability; D006801:Humans; D007124:Immunoenzyme Techniques / Q000592:standards / Q000706:statistics & numerical data; D007249:Inflammation / Q000097:blood; D012015:Reference Standards; D012016:Reference Values; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D000685:Serum Amyloid A Protein / Q000032:analysis*
D000685:Serum Amyloid A Protein